The long and winding road of non steroidal antinflammatory drugs and paracetamol in cancer pain management: A critical review

Critical Reviews in Oncology/Hematology

Volumn 87, Issue 2, 2013, Pages 140-145

  Mercadante, Sebastiano ^a,b   Giarratano, Antonino ^a,b  

^a LA MADDALENA CANCER CENTER   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Anti inflammatory drugs; Cancer pain; Paracetamol

Indexed keywords

DEXKETOPROFEN; DIPYRONE; KETOPROFEN; KETOROLAC; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO;

BONE PAIN; CANCER PAIN; CONSTIPATION; CONTINUOUS INFUSION; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; GASTRIC DISCOMFORT; HUMAN; PATIENT CONTROLLED ANALGESIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STOMACH DISEASE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTI-INFLAMMATORY DRUGS; CANCER PAIN; PARACETAMOL;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; NEOPLASMS; PAIN; PAIN MANAGEMENT; TREATMENT OUTCOME;

EID: 84881244472     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2013.01.001     Document Type: Review

References (22)

1. Ripamonti C., Bandieri E. Pain therapy. Critical Reviews in Oncology/Hematology 2009, 70:145-159.
2. Urban D., Cherny N., Catane R. The management of cancer pain in the elderly. Critical Reviews in Oncology/Hematology 2010, 73:176-183.
3. McNicol E., Strassels S.A., Goudas L., et al. NSAIDs or paracetamol, alone or combined with opioids for cancer pain. Cochrane Database of Systematic Reviews 2005, CD005180.
4. Nabal M., Librada S., Redondo M.J., Pigni A., Brunelli C., Caraceni A. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO step III opioids in the control of pain in advanced cancer. mA systematic review of the literature. Palliative Medicine 2012, 26:305-312.
5. Mercadante S. The use of anti-inflammatory drugs in cancer pain. Cancer Treatment Reviews 2001, 27:51-61.
6. Rodriguez R.F., Castillo J., Castillo M.P., et al. Hydrocodone/acetaminophen and tramadol chlorhydrate combination tablets for the management of chronic cancer pain: a double-blind comparative trial. Clinical Journal of Pain 2008, 24:1-4.
7. Rodriguez R.F., Castillo J., Castillo M.P., et al. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23 days, prospective, double-blind, randomized, parallel-group study. Clinical Therapeutics 2007, 29:581-587.
8. Sima L., Fang W.X., Wu X.M., Li F. Efficacy of oxycodone/paracetamol for patients with bone cancer pain: a multicenter, randomized, double-blind, placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics 2011, 37:27-31.
9. Xu J.M., Song S.T., Feng F.Y., et al. Cobrotoxin-containing analgesic compound to treat chronic moderate to severe cancer pain: results from a randomized, double-blind, cross-over study and from an open-label study. Oncology Reports 2006, 16:1077-1084.
10. Chou R., Qaseem A., Snow V., et al. Clinical efficacy assessment subcommittee of the American college of physicians; American College of Physicians; American Pain Society Low Back Pain Guidelines Panel. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Annals of Internal Medicine 2007, 147:478-491.
11. Dagenais S., Tricco A.C., Haldeman S. Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines. Spine Journal 2010, 10:514-529.
12. Axelsson B., Borup S. Is there an additive analgesic effect of paracetamol at step 3?. A double-blind randomized controlled study. Palliative Medicine 2003, 17:724-725.
13. Stockler M., Vardy J., Pillai A., Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trail. Journal of Clinical Oncology 2004, 22:3389-3394.
14. Farrar J.T., Young J.P., LaMoreaux L., Werth J.L., Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001, 94:149-158.
15. Tasmacouglu B., Aydinli I., Keskinbora K., Pekel A., Salihoglu T., Sonsuz A. Effect of intravenous administration of paracetamol on morphine consumption in cancer pain control. Supportive Care in Cancer 2009, 17:1475-1481.
16. Israel F., Couns M., Parker G., et al. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. Journal of Pain and Symptom Management 2010, 39:548-554.
17. Cubero D., del Giglio A. Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study. Supportive Care in Cancer 2010, 18:235-242.
18. Duarte-Souza J., Lajolo P., Pinczowski H., del Giglio A. Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better. Supportive Care in Cancer 2007, 15:1319-1323.
19. Mercadante S., Fulfaro F., Casuccio A. A randomized controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. European Journal of Cancer 2002, 38:1358-1363.
20. Rodriguez M., Contreras D., Galvez R., et al. Double-blind evaluation of short term analgesic efficacy of orally administered dexketoprofen trometamol and ketorolac in bone cancer pain. Pain 2003, 104:103-110.
21. Moselli N.M., Cruto M., Nassucco P., Savojardo, Debernardi F. Long-term continuous subcutaneous infusion of ketoprofen combined with morphine: a safe and effective approach to cancer pain. Clinical Journal of Pain 2010, 26:267-274.
22. Serlin R.C., Mendoza T.R., Nakamura Y., Edwards K.R., Cleeland C.S. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995, 61:277-284.